The Fund aims to achieve longterm capital growth.
Name | % Net Assets |
---|---|
Allianz SE | 2.2% |
Sanofi-Aventis S.A. | 2.0% |
Novartis AG | 1.9% |
Enagas S.A. | 1.8% |
Red Electrica Corp. S.A. | 1.8% |
Heineken N.V. | 1.7% |
France Telecom | 1.7% |
Danone S.A | 1.6% |
Koninklijke Ahold N.V. | 1.6% |
SAP AG | 1.6% |
Key | % Net Assets |
---|---|
Allianz SE | 2.2% |
Sanofi-Aventis S.A. | 2.0% |
Novartis AG | 1.9% |
Enagas S.A. | 1.8% |
Other | 92.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 1,084.00p |
Currency | GBP |
Change | -7.00p |
% | -0.64% |
YTD change | -27.00p |
YTD % | -2.43% |
Fund Inception | 28/03/1989 |
---|---|
Fund Manager | Chris Rice |
TER | 1.09 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £25000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research